News on Recover and Rehab Issues
Darwen rehab centre decision on hold
DOZENS of protesters came to learn whether controversial plans for a rehab centre in their area would get the go-ahead.
$1.3b obesity drug deal signed
NEW YORK - SHARES of Orexigen Therapeutics Inc surged on Thursday after the drugmaker said it signed a US$1 billion (S$1.34 billion) co-development agreement for its experimental obesity drug Contrave with Takeda Pharmaceuticals. Under the deal, Orexigen will receive US$50 million upfront from Takeda, Japan's largest drugmaker.
Has Therapy Become Too "Hands Off?"
After speaking to a patient the other day, it was conveyed that she felt her therapy sessions had become too "hands off." After being taught an exercise this patient would perform it independently while the therapist treated another patient at the same time.
...Read Full Post
Developing a Drug-Free Lifestyle
